1.220USD-2.40%Mkt Cap: 378.93M USDP/E: —Last update: 2026-05-22
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single mol…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Company
Market Cap378.93M USD
Enterprise Value818.68M USD
Revenue (TTM)160.03M USD
Gross Profit45.78M USD
Net Income (TTM)-546.38M USD
Revenue/Share0.5300 USD
Last Price1.220 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees485
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS69404D1081
Valuation
P/E (Trailing)—
P/E (Forward)-3.11
PEG—
EV/EBITDA-5.72
EV/Revenue5.12
P/S2.43
P/B156.25
EPS (TTM)-0.41
EPS (Forward)-0.40
52W Range
0.850020% of range2.730
52W High2.730 USD
52W Low0.8500 USD
Profitability
Gross Margin28.61%
Oper. Margin-102.89%
EBITDA Margin-89.45%
Profit Margin-341.47%
ROE-10214.54%
ROA-69.68%
Growth
Revenue Growth0.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-111.21M USD
CapEx (TTM)7.71M USD
FCF Margin-30.14%
FCF Yield-12.73%
Net Debt430.43M USD
Net Debt/EBITDA-3.01
Balance Sheet
Debt/Equity131.32
Current Ratio5.65
Quick Ratio4.67
Book Value/Sh0.0080 USD
Cash/Share0.8880 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Target (Mean)2.458 USD
Target Range1.500 USD – 3.000 USD
# Analysts6
Ownership
Shares Out.310.60M
Float302.35M
Insiders8.77%
Institutions54.05%
Short Interest
Short Ratio7.3d
Short % Float17.43%
Short % Out.15.16%
Shares Short47.09M
Short (prev mo.)45.63M
Technical
SMA 501.429 (-14.6%)
SMA 2001.672 (-27.0%)
Beta2.40
S&P 52W Chg28.31%
Avg Vol (30d)6.28M
Avg Vol (10d)6.61M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—